Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Glioblastoma Exosomes for Therapeutic Angiogenesis in Peripheral Ischemia
Anthony Monteforte
, Brian Lam
,
Michael B. Sherman
, Kayla Henderson
, Andrew D. Sligar
, Adrianne Spencer
, Brian Tang
, Andrew K. Dunn
, Aaron B. Baker
Biochemistry & Molecular Biology
Research output
:
Contribution to journal
›
Article
›
peer-review
32
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Glioblastoma Exosomes for Therapeutic Angiogenesis in Peripheral Ischemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Exosomes
100%
Glioblastoma
100%
Peripheral Ischemia
100%
Therapeutic Angiogenesis
100%
Angiogenic
50%
Fibroblast Growth factor-2 (FGF-2)
25%
Revascularization
25%
Vessel Development
25%
Angiogenic Therapy
25%
Angiogenic Factors
12%
Clinical Trials
12%
Ischemia
12%
Next-generation Sequencing
12%
Tumor Cells
12%
Tumor
12%
Blood Vessels
12%
Peripheral Vascular Disease
12%
Healing
12%
High Concentration
12%
Angiogenesis
12%
Co-receptor
12%
Extracellular Vesicles
12%
Surgical Intervention
12%
Hindlimb Ischemia
12%
Percutaneous Intervention
12%
Endothelial Cell Proliferation
12%
Immunomodulatory
12%
Tumor Subtype
12%
MicroRNA Expression
12%
Ischemic Disease
12%
Syndecan-4
12%
Chemotherapy Resistance
12%
Proteoglycan
12%
Angiogenic Tumors
12%
Tubule Formation
12%
MiR-221
12%
Glypican
12%
Sol-gel Growth
12%
Alginate Gel
12%
Biochemistry, Genetics and Molecular Biology
Angiogenesis
100%
Basic Fibroblast Growth Factor
100%
Solution and Solubility
50%
Cell Proliferation
50%
MicroRNA
50%
Clinical Trial
50%
Co-Receptor
50%
Next Generation Sequencing
50%
Proteoglycan
50%
Alginate
50%
Glypican 1
50%
Syndecan
50%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Peripheral Ischemia
100%
Ischemia
50%
Neoplasm
50%
Fibroblast Growth Factor 2
33%
Clinical Trial
16%
Receptor
16%
microRNA
16%
Proteoglycan
16%
Angiogenic Factor
16%
Peripheral Occlusive Artery Disease
16%
Syndecan 4
16%
microRNA 221
16%
Glypican 1
16%
Alginic Acid
16%
Neuroscience
Angiogenesis
100%
Ischemia
100%
Exosome
100%
Basic Fibroblast Growth Factor
25%
In Vitro
12%
Vascular Disease
12%
Cell Proliferation
12%
MicroRNA
12%
Angiogenic Factor
12%
Proteoglycan
12%
Syndecan 4
12%
Glypican 1
12%
microRNA 221
12%
Co-Receptor
12%
Alginic Acid
12%